SCHEMBL30764804

SCHEMBL30764804

CCCc1cc(OC(F)(F)F)ccc1Nc1ccc2ccccc2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
GAA P10253 1/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
ACP1 P24666 1/20 0.45
HTT P42858 1/20 0.40
NCF1 P14598 1/20 0.38
IGF1R P08069 1/20 0.37
PIM1 P11309 1/20 0.37
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
PDE10A Q9Y233 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21617054 1.00 SMN1; SMN2 (0.45) SMN1; SMN2NPC1RAB9AKDM4EALDH1A1
SCHEMBL30764791 0.91 SMN1; SMN2 (0.47) SMN1; SMN2NPC1RAB9AKDM4EALDH1A1
SCHEMBL21617089 0.91 SMN1; SMN2 (0.47) SMN1; SMN2NPC1RAB9AKDM4EALDH1A1
SCHEMBL21617074 0.83 NPC1 (0.43) SMN1; SMN2NPC1RAB9AKDM4EALDH1A1
SCHEMBL30764821 0.83 NPC1 (0.43) SMN1; SMN2NPC1RAB9AKDM4EALDH1A1
SCHEMBL21617034 0.83 XPO1 (0.35) PIM1CTSSCTSKDHFRHRH4
SCHEMBL30764839 0.83 XPO1 (0.35) PIM1CTSSCTSKDHFRHRH4
SCHEMBL1702074 0.82 NPC1 (0.50) SMN1; SMN2NPC1RAB9AKDM4EALDH1A1
SCHEMBL21617032 0.79 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9AKDM4EALDH1A1
SCHEMBL30764845 0.79 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112566899-B phenyl-N-quinoline derivatives for the treatment of RNA viral infections ABIVAX公司 2024-01-30 CN disclosed